Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas
- PMID: 11259092
- PMCID: PMC2363823
- DOI: 10.1054/bjoc.2000.1672
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas
Abstract
Since the few data exploring a possible association between Epstein-Barr virus (EBV) and breast cancer are conflicting, we investigated this association together with the influences of geographical areas. 509 breast cancers were sampled from areas with varying risks of nasopharynx carcinoma (NPC) such as North Africa (Algeria and Tunisia, high-risk area); southern France (Marseille, intermediate-risk area); and northern Europe (northern France, the Netherlands and Denmark; low-risk areas). Polymerase chain reaction (PCR) of a subregion of EBV BamHIC encoding the EBERs demonstrated that 31.8% of the tumours contained the viral genome. No significant differences were observed among the geographical areas. However, positive samples showed higher loads of the EBV genome in the NPC high- and intermediate-risk areas than in the low-risk areas. EBV type 1 was the dominant strain. In situ hybridization studies using a(35)S-labelled riboprobe for EBER1 and a laser capture microdissection, combined with quantitative PCR, showed that EBV localization was restricted to some tumour epithelial cell clusters. EBV could not be detected in the stroma. Considering the whole population covered, the presence of the EBV genome was not correlated with age, menopausal status, tumour, size, nodal status or histological grade.
Copyright 2001 Cancer Research Campaign.
Similar articles
-
Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.Cancer Res. 2003 May 1;63(9):2338-43. Cancer Res. 2003. PMID: 12727860
-
Epstein-Barr virus in epithelial cell tumors: a breast cancer study.Cancer Res. 1995 Jan 1;55(1):39-45. Cancer Res. 1995. PMID: 7805038
-
Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization.J Pathol. 2002 Aug;197(5):684-8. doi: 10.1002/path.1141. J Pathol. 2002. PMID: 12210090
-
Epstein-Barr virus-associated lymphoepithelioma-like carcinoma of the esophagus.Hum Pathol. 2003 Apr;34(4):407-11. doi: 10.1053/hupa.2003.71. Hum Pathol. 2003. PMID: 12733124 Review.
-
Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis.Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):688-97. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15159298 Review.
Cited by
-
The viral origins of breast cancer.Infect Agent Cancer. 2024 Aug 26;19(1):39. doi: 10.1186/s13027-024-00595-2. Infect Agent Cancer. 2024. PMID: 39187871 Free PMC article. Review.
-
Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases.Pathogens. 2023 Nov 24;12(12):1387. doi: 10.3390/pathogens12121387. Pathogens. 2023. PMID: 38133273 Free PMC article.
-
Epstein-Barr Viral Infection and the Risk for Breast Cancer: A Systematic Review.Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):114-124. doi: 10.18502/ijhoscr.v17i2.12650. Int J Hematol Oncol Stem Cell Res. 2023. PMID: 37637768 Free PMC article. Review.
-
Exploring the link between viruses and cancer in companion animals: a comprehensive and comparative analysis.Infect Agent Cancer. 2023 Jun 29;18(1):40. doi: 10.1186/s13027-023-00518-7. Infect Agent Cancer. 2023. PMID: 37386451 Free PMC article. Review.
-
Detection of Epstein Barr Nuclear Antigen-1 (EBNA-1), Early Antigen 1F, 2R (EA-1F, EA- 2R) along with Epstein-Barr virus Latent Membrane Protein 1 (LMP1) in Breast Cancer of Northern India: An Interim Analysis.Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3717-3723. doi: 10.31557/APJCP.2022.23.11.3717. Asian Pac J Cancer Prev. 2022. PMID: 36444584 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
